Clinical Trial Update: Expanded Access Program (EAP) STIMULAN VG

View source ↗

Summary

Expanded Access Program update for Stimulan VG indicates the program is AVAILABLE for use in Stage IV pressure ulcers and diabetic foot osteomyelitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Osteomyelitis
• Pressure Ulcer

Drugs mentioned

• Stimulan VG (calcium sulfate bone graft substitute)

Snippet

Sponsor: Biocomposites Ltd | Conditions: Stage IV Pressure Ulcer, Diabetic Foot Osteomyelitis | Status: AVAILABLE